- Home
- ACHL vs JZXN Comparison
ACHL vs JZXN Comparison
Compare ACHL & JZXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHL
- JZXN
- Stock Information
- Founded
- ACHL 2016
- JZXN 2017
- Country
- ACHL United Kingdom
- JZXN China
- Employees
- ACHL N/A
- JZXN N/A
- Industry
- ACHL Biotechnology: Biological Products (No Diagnostic Substances)
- JZXN Retail-Auto Dealers and Gas Stations
- Sector
- ACHL Health Care
- JZXN Consumer Discretionary
- Exchange
- ACHL Nasdaq
- JZXN Nasdaq
- Market Cap
- ACHL 46.0M
- JZXN 45.5M
- IPO Year
- ACHL 2021
- JZXN 2021
- Fundamental
- Price
- ACHL $1.38
- JZXN $4.37
- Analyst Decision
- ACHL Buy
- JZXN
- Analyst Count
- ACHL 2
- JZXN 0
- Target Price
- ACHL $4.00
- JZXN N/A
- AVG Volume (30 Days)
- ACHL 1.9M
- JZXN 171.1K
- Earning Date
- ACHL 04-03-2025
- JZXN 09-09-2024
- Dividend Yield
- ACHL N/A
- JZXN N/A
- EPS Growth
- ACHL N/A
- JZXN N/A
- EPS
- ACHL N/A
- JZXN N/A
- Revenue
- ACHL N/A
- JZXN $7,597,423.00
- Revenue This Year
- ACHL N/A
- JZXN N/A
- Revenue Next Year
- ACHL N/A
- JZXN N/A
- P/E Ratio
- ACHL N/A
- JZXN N/A
- Revenue Growth
- ACHL N/A
- JZXN 81.94
- 52 Week Low
- ACHL $0.63
- JZXN $1.00
- 52 Week High
- ACHL $1.76
- JZXN $67.60
- Technical
- Relative Strength Index (RSI)
- ACHL 72.41
- JZXN 70.40
- Support Level
- ACHL $1.10
- JZXN $3.53
- Resistance Level
- ACHL $1.41
- JZXN $6.46
- Average True Range (ATR)
- ACHL 0.02
- JZXN 0.74
- MACD
- ACHL 0.00
- JZXN 0.17
- Stochastic Oscillator
- ACHL 90.48
- JZXN 55.05
About ACHL Achilles Therapeutics plc
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.
About JZXN Jiuzi Holdings Inc.
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its business segments are sales of NEVs and Franchisees services. The company generates a majority of its revenue from the NEVs segment. Geographically, the firm operates in China.